Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6031 AL 6045

Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial

Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O.

Trials. 2011 Oct 20;12:230. doi: 10.1186/1745-6215-12-230.

Treatment of Alzheimer disease: the past, the present, and the future

Gauthier S.

Can J Psychiatry. 2011 Oct;56(10):577-8. doi: 10.1177/070674371105601001.

Pharmacological treatment of Alzheimer disease

Massoud F, Léger GC.

Can J Psychiatry. 2011 Oct;56(10):579-88. doi: 10.1177/070674371105601003.

Nonpharmacological treatment of Alzheimer disease

Ballard C, Khan Z, Clack H, Corbett A.

Can J Psychiatry. 2011 Oct;56(10):589-95. doi: 10.1177/070674371105601004.

Elevation of glutathione as a therapeutic strategy in Alzheimer disease

Pocernich CB, Butterfield DA.

Biochim Biophys Acta. 2012 May;1822(5):625-30. doi: 10.1016/j.bbadis.2011.10.003. Epub 2011 Oct 12.

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

Mecocci P, Polidori MC.

Biochim Biophys Acta. 2012 May;1822(5):631-8. doi: 10.1016/j.bbadis.2011.10.006. Epub 2011 Oct 13.

Nanotherapeutics for Alzheimer's disease (AD): Past, present and future

Fazil M, Shadab, Baboota S, Sahni JK, Ali J.

J Drug Target. 2012 Feb;20(2):97-113. doi: 10.3109/1061186X.2011.607499. Epub 2011 Oct 25.

Effectiveness of interventions to prevent falls in people with Alzheimer's disease and related dementias

Jensen LE, Padilla R.

Am J Occup Ther. 2011 Sep-Oct;65(5):532-40. doi: 10.5014/ajot.2011.002626.

Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease

Miller BW, Willett KC, Desilets AR.

Ann Pharmacother. 2011 Nov;45(11):1416-24. doi: 10.1345/aph.1Q238. Epub 2011 Oct 25.

[Alzheimer: destiny of a disease]

Deleuze J.

Rev Prat. 2011 Sep;61(7):891.

Hybrid-based multi-target ligands for the treatment of Alzheimer's disease

Rampa A, Belluti F, Gobbi S, Bisi A.

Curr Top Med Chem. 2011 Nov;11(22):2716-30. doi: 10.2174/156802611798184409.

Multitarget-directed ligands: innovative chemical probes and therapeutic tools against Alzheimer's disease

Bolognesi ML, Simoni E, Rosini M, Minarini A, Tumiatti V, Melchiorre C.

Curr Top Med Chem. 2011 Nov;11(22):2797-806. doi: 10.2174/156802611798184373.

1,8-Naphthyridine derivatives as cholinesterases inhibitors and cell Ca2+ regulators, a multitarget strategy for Alzheimer's disease

Egea J, de los Rios C.

Curr Top Med Chem. 2011 Nov;11(22):2807-23. doi: 10.2174/156802611798184418.

Psychometric evaluation of the Swedish version of the Person-Centered Care Assessment Tool (P-CAT)

Sjögren K, Lindkvist M, Sandman PO, Zingmark K, Edvardsson D.

Int Psychogeriatr. 2012 Mar;24(3):406-15. doi: 10.1017/S104161021100202X. Epub 2011 Nov 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias